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In terms of population, India is the second largest 
country in the world with more than 1.3 billion 
populations. Despite being fastest growing economy, it 
stands way behind in terms of education, standard of 
living and health.1 Oral health is a critical but 
overlooked component of overall health and well-being 
among adults.2 Despite being largely preventable, oral 
diseases are highly prevalent throughout the life course 
and have substantial negative effects on individals.3,4,5 
In modern society, a number of diseases have been on 
the rise with changing lifestyles or environmental 
influences including diet and psychoemotional stress. 
Such impact may continue to the development and 
prevalence of various diseases including 
arteriosclerosis, cancer, chronic liver disease/ cirrhosis, 
chronic obstructive pulmonary disease (COPD), 
diabetes, hypertension, heart diseases, stroke, 
recurrent aphthous stomatitis, asthma, obesity, 
depression and vascular dementia.6,7 
 
In an otherwise healthy individual, there are few 
conditions that develop in the oral mucosa. Aphthous 
ulcerations, commonly referred to as “canker sores,” 
are the most prevalent oral mucosal lesions which 
affects the population more than 20%. The term 
“aphthous” is derived from a Greek word “aphtha” 
which means ulceration.8 Recurrent aphthous 
stomatitis (RAS) has been described under three 
different clinical variants as classified by Stanley in  
 
 
1972. Mikulicz’s aphthae are the mild RAS or mild 
aphthous ulcers, major RAS also known as periadenitis 
mucosa necrotica recurrens or Sutton’s disease, and 
Herpetiform ulceration characterized by recurrent 
crops of multiple ulcers which may be up to 100 in 
number.9 
 
It is a distinct oral condition of unknown etiology 
characterized by the spontaneous emergence of more 
than 2 bouts of oral ulcers per year, not associated with 
an underlying systemic abnormality.10 The outbreak of 
RAS are associated with hereditary, psychological and 
socioeconomic stresses; nutritional deficiencies; 
hormonal fluctuations; and immunologic 
deficiencies.11-16 There is some evidence that suggests 
RAS ulcers are related to modified immunologic 
defenses or may be symptoms of several pathogens, 
rather than one. Due to the indeterminant aetiology of 
these lesions, it is often difficult to find a definitive 
cure.17,18,19 
 
Several agents are helpful in the management of 
aphthous ulcers including antibiotics, anti-
inflammatory, immune modulators, anesthetics and 
alternative products.20 In most patients, topical agents 
including over the counter preparation such as 
antiseptic mouthwashes are recommended.21 Topical 
agents enhances reparative and regenerative processes, 
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processes and oxidative phosphorylation, increases 
oxygen consumption in vitro and stimulate the 
transport of glucose into the cells. 
 
Currently used topical antibacterial, anti-
inflammatory, immunomodulatory or symptomatic 
treatments for the condition are neither 100% reliable 
nor efficacious. There is currently no single well- 
established treatment for these common mouth ulcers, 
and none of the existing treatments accelerate the 
healing process.21-25 
 
Recently, lasers have been used to treat various forms 
of oral lesions including RAS because of its 
biomodulation, analgesic effect by stimulation of 
healing process, promoting immediate relief of pain 
without an overdose of medication or side-effects and 
prevention of recurrence.8,26 Studies have suggested 
that low-level laser therapy (LLLT) has the potential to 
treat aphthous ulcer and related lesions. It is a safe and 
clinically effective therapy for treating RAS which also 
provides time benefit to the patients.8 This measure of 
treatment gives the dentist an interesting opportunity 
to expand the range of services offered in the practice 
and to alleviate the discomfort of patients quickly and 
easily. 
 
The clinical case reports of the subjects reported with 
aphthous ulcer describes and analyzes the diagnosis 
and/or the management of one or two patients acts as 
the first line of evidence in health care. This case series 
is a powerful source to disseminate information on 
unusual clinical syndromes, disease associations, 
unusual side effects to therapy, or response to 
treatment. Case reports regarding aphthous ulcers and 
their treatment may be used as a means to teach health 
sciences students. Therefore, the aim of this paper is to 
critically appraise and epitomize clinical studies to 
ascertain whether laser therapy is an effective 
treatment option for treating aphthous ulcer through 
this case series. 
 
CASE REPORTS 
Three patients with the chief complaint of recurrent 
painful ulcers in the oral cavity came to the 
institutional department of Oral Medicine and 
Radiology. On clinical examination, oral ulcers of 
different dimensions were observed having 
erythematous halo on buccal mucosa, labial mucosa, 
tongue, floor of the mouth etc.  The diagnosis of 
recurrent aphthous ulcers was made on the basis of 
detailed medical history and the clinical criteria given 
by Natah et al. in 2004. A meticulous history was taken 
to eliminate other ulcerative conditions such as 
Crohn’s disease, celiac disease, neutropenia, HIV 
infection, and Behcet’s syndrome. An informed 
consent was taken and an information sheet consisting 
of all the details of the procedure was provided to all 
the patients. 
 
All the patients reported with the recurrent history of 
aphthous ulcers were provided with Low Level Laser 
Therapy (LLLT) for three consecutive days of 
wavelength 940nm diode laser, which was started 
using 320µm fiber optic at a distance of 1-3 mm from 
the lesion. It was provided with circular motion from 
the periphery of the ulcer to the center for 2 cycles with 
100% duty for 30 seconds. The estimation of reduction 
in pain was done using VAS score 0 to 10 and in size of 
the ulcer using divider and ruler with an accuracy of 1 
mm. The recordings were made just before the 




A 78-year-old patient presented an 8 week history of 
episodes of recurrent aphthous ulcers on the labial 
mucosa [figure 1(a)]. Patient had difficulty in speech 
and while eating. The size of the ulcer was 2.5 mm in 
length and 5.5 mm in width. The ulcer was not 
associated with any type of discharge and was tender 
on palpation. The patient used various 
chemotherapeutic aids such as topical anaesthetics for 
the management of aphthous ulcer, but the lesion 
recurred. He was provided with the laser therapy and 
lesion was observed for healing [figure 1(b)]. The 
readings of the reduction in ulcer pain and size are 




A 23-year-old patient presented a 3 months history of 
recurrent aphthous ulcers on the floor of the mouth 
[figure 2(a)]. She had difficulty while chewing and  
 
 SCORES 
Day 1 Day 2 Day 3 
Size of the 
ulcer (in mm) 
2.5 x 5.5 
mm 
2.5 x 4.5 
mm 
1.5 x 4 mm 
Pain perceived 
(scale 0-10) 
10 7 0 
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speaking. The size of the ulcer was 4 mm in length and 
6 mm in width. The ulcer was very tender to palpate. 
She tried various home remedies for treating aphthous 
ulcers but it kept on recurring. She was provided with 
low level laser therapy. She reported that ulcer started 
to heal early than the previous times and also there was 
immediate reduction in pain after the first exposure to 
the laser therapy [figure 2(b)]. The readings of the 
reduction in ulcer pain and size are given in table 2. 
 
 SCORES 
Day 1 Day 2 Day 3 
Size of the 
ulcer (in mm) 

















A 42-year-old patient reported a history of 2 months 
recurrence of aphthous ulcers on the ventral surface of 
the tongue [figure 3(a)]. He faced difficulty to speak, 
drink and while chewing. The size of the ulcer was 6 
mm in length and 3 mm in width. The ulcer was round 
with erythematous halo. It was not associated with any 
type of discharge and was highly tender to palpate. The 
medical and family history were not of any 
contribution. The patient used pharmacological modes 
such as topical application of lignocaine and systemic 
vitamin B complex, which caused no improvement in 
discomfort and pain of the aphthous ulcer. He was 
given treatment using low level laser therapy to heal 
the lesion. He reported complete relief of pain and 
significant reduction in size of ulcer in 4 days and there 
was no discomfort. There were no side-effects reported 
of LLLT in the patient [figure 3(b)]. The readings of the 
reduction in ulcer pain and size are given in table 3. 
 
 SCORES 
Day 1 Day 2 Day 3 
Size of the 
ulcer (in mm) 
6 x 3 mm 4 x 2.5 
mm 

















The aphthous ulcers may occur in the oral cavity due 
to differential reasons. While evaluating the patients 
with oral symptoms, Infection-causing ulceration in 
the mouth should also be considered. A common 
infection, particularly in patients with HIV infection 
and aphthae is herpes.  Other viral, bacterial, 
treponemal and fungal agents have the potential to 
cause mouth ulcers. Several autoimmune diseases may 
mimic benign aphthous ulcers. Behçet's syndrome is an 
autoimmune vasculitis that causes recurrent oral and 
genital ulcerations, uveitis and retinitis. Lupus 
erythematosus, bullous pemphigoid and pemphigus 
vulgaris are other diseases that may involve ulceration 
of the mouth. In all of these conditions, the associated 
symptoms should be elicited to make a differentiation 
from benign recurrent aphthae.27 
 
Numerous agents aids in the management of aphthous 
ulcers including antibiotics, anti-inflammatory, 
Table 2. Ulcer pain and size score at three-point times  
(Case II) 
Table 3. Ulcer pain and size score at three-point times  
(Case III) 




Figure 2. Case II (a) Pre-treatment and (b) Post-treatment  
(a) (b) 
Figure 3. Case III (a) Pre-treatment and (b) Post-treatment  
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immune modulators, anaesthetics and alternative 
products.6 Topical agents enhances reparative and 
regenerative processes, provides to activation of 
aerobic metabolic processes and oxidative 
phosphorylation, increases oxygen consumption and 
stimulate the transport of glucose into the cells.7 
Pertaining to pain relief, one mechanism that has been 
proposed is modulation of pain perception by 
modification of nerve conduction via the release of 
endorphins and enkephalins.8 The main purpose of 
treatment is to decrease pain and size of the ulcer.9 The 
results of the study conducted showed that Low Level 
Laser Therapy has the magnitude of reducing the pain 
intensity and size of aphthous ulcers. Healing is the 
main characteristic of LLLT including three main 
factors. First, there is an increment of adenosine 
triphosphate (ATP) production, as laser is considered 
to raise the production of ATP, leading to a boost in 
mitotic activity and to an increase in protein synthesis 
by mitochondria, resulting in greater tissue 
regeneration in the repair process. Second, there is a 
stimulus to microcirculation, which increases the 
delivery of nutritional elements associated with 
increased speed of mitosis, facilitating cell 
multiplication. Finally, new vessels are formed from 
pre existing vessels.9 A study conducted by De Souza et 
al. in 2010 revealed that 75% of the patients reported a 
reduction in pain in the same session after laser 
treatment and total regression of the lesion occurred 
after 4 days.28 Khademi et al. found similar benefits of 
quicker healing and reduced pain after using low levels 
of laser treatment on RAS.29 Similarly the LLLT study 
was effective in relieving pain and reducing the healing 
time during the treatment of aphthous ulcers 
conducted by Aggarwal et al.30 
 
Hence it summarizes, as there are no medications, the 
side effects and risk of overdosage could also be 
prevented. Hence, it can be concluded that LLLT is a 
safe and clinically effective therapy for treating RAUs, 
which also provides time benefit to the patients. The 
outcomes from the present study which standout are, 
the immediate and lasting pain relief, and the 
accelerated ulcer healing. Limitation of the study 
includes subjective evaluation of pain perception. 
Though healing occurs through medications and laser 
therapy but mainly depends on host immune response 
and microbe interaction. 
 
CONCLUSION  
LLLT employed as a treatment measure for the 
management of recurrent aphthous ulcers in the  
current case report not only provided instant pain relief 
but a rapid decrease in the size of the lesion was also 
seen. It is safe, clinically effective therapy for treating 
RAU, which also provides time benefit to the patients. 
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